Open-label, Multicenter Study Assessing Preference for Deferasirox Film-coated Tablet Compared to Dispersible Tablet

Clinical trial NCT02993224 · COMPLETED

Trial details

NCT number: NCT02993224
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Transfusion-dependent Thalassemia Non-transfusion-dependent Thalassemia

Start date: 2017-07-27
Primary completion: 2020-01-29
Enrollment: 148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.